Saturday, July 11, 2026

Drug profile · INN

edotreotide

edotreotide (SOMAKIT TOC) is an FDA-listed pharmaceutical active ingredient.

EMA: approved Various (V09) V09IX
Patents linked 0
Pipeline programs 2
News articles 0
Drug details — edotreotide
Class
Various (V09)
Route
Patents
0
Programs
2
Data quality
0.83

Quick answer

edotreotide (SOMAKIT TOC) is an FDA-listed pharmaceutical active ingredient.

Key facts

INN edotreotide
Brand SOMAKIT TOC
Therapeutic class Various (V09)
ATC code V09IX

Approval history

Authority Status Date
EMA approved

Pipeline programs

  1. IRST100.60 Phase 2 · Istituto Gentili Italia · NET, Neuroendocrine Tumor, Other SSTR-positive tumours, NETs
  2. SomaKit TOC 40 micrograms kit for radiopharmaceutical preparation Approved · Ningbo Cancer Hospital · Gastroenteropancreatic neuroendocrine tumors

Related & competitor drugs

  1. besilesomab Various (V09)
  2. deferasirox Various (V03)
  3. ferric citrate coordination complex Various (V03)
  4. folic acid Various (V04)
  5. sevelamer carbonate Various (V03)
  6. sugammadex sodium Various (V03)

Frequently asked questions

What is edotreotide?

edotreotide (SOMAKIT TOC) is an FDA-listed pharmaceutical active ingredient.

What is the brand name for edotreotide?

SOMAKIT TOC is a marketed brand name for edotreotide. Check FDA Drugs@FDA for the current US label holder and prescribing information.